Early changes in the gut microbiota are associated with weight outcomes over 2 years following metabolic and bariatric surgery
Obesity · 2024-11 · 32 (11) · 1985-1997
DOI: 10.1002/oby.24168 ↗At a glance
Journal article in Obesity, published online on 2024-11-05. Written by Kristine J Steffen and 7 co-authors. Institution: Department of Pharmaceutical Sciences, School of Pharmacy, College of Health and Human Sciences, North Dakota State University, Fargo, North Dakota, …. Major MEDLINE topics: Gastrointestinal Microbiome, Bariatric Surgery, Weight Loss. Cited 9 times so far (Crossref); 19 references. Funded by: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (original language)
Objective
Metabolic and bariatric surgery (MBS) is associated with substantial, but variable, weight outcomes. The gut microbiome may be a factor in determining weight trajectory, but examination has been limited by a lack of longitudinal studies with robust microbiome sequencing. This study aimed to describe changes in the microbiome and associations with weight outcomes more than 2 years post surgery.
Methods
Data were collected at two Midwestern U.S. centers. Adults undergoing primary MBS were assessed before and 1, 6, 12, 18, and 24 months after surgery. BMI and metagenomic sequencing occurred at each assessment. A linear growth mixture model determined class structure for weight trajectory.
Results
A linear growth mixture model of participants ( N = 124) revealed a two‐class structure; one class had greater sustained weight loss relative to the other. Greater genus‐level taxonomic changes in the microbiome composition at each time point were associated with being in the more favorable weight trajectory class, after controlling for surgery type. Higher Proteobacteria relative abundance at 1 month was predictive of percentage weight change at 6, 12, 18, and 24 months ( p < 0.05 for all).
Conclusions
Greater genus‐level taxonomic changes in the gut microbiota are associated with improved weight trajectory. Early changes in the gut microbiota may be an important indicator of MBS outcomes and durability.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- Department of Pharmaceutical Sciences, School of Pharmacy, College of Health and Human Sciences, North Dakota State University, Fargo, North Dakota, USA.
- Sanford Center for Biobehavioral Research, Fargo, North Dakota, USA.
- Department of Bioinformatics and Genomics, University of North Carolina, Charlotte, North Carolina, USA.
- Department of Nutrition, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA.
- Center for Obesity Research, Innovation, and Education, Digestive Health Institute, Hartford Hospital/Hartford HealthCare, Hartford, Connecticut, USA.
- Department of Psychiatry and Psychology, Cleveland Clinic, Cleveland, Ohio, USA.
ORCID profiles: Kristine J Steffen, Alicia A Sorgen, Dale S Bond
Funding
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
Cite
APA
Steffen, K. J., Sorgen, A. A., Fodor, A. A., Carroll, I. M., Crosby, R. D., Mitchell, J. E., Bond, D. S., & Heinberg, L. J. (2024). Early changes in the gut microbiota are associated with weight outcomes over 2 years following metabolic and bariatric surgery. Obesity, 32(11), 1985-1997. https://doi.org/10.1002/oby.24168
Vancouver
Steffen KJ, Sorgen AA, Fodor AA, Carroll IM, Crosby RD, Mitchell JE, et al. Early changes in the gut microbiota are associated with weight outcomes over 2 years following metabolic and bariatric surgery. Obesity. 2024;32(11):1985-1997. doi:10.1002/oby.24168
BibTeX
@article{Steffen2024,
author = {Steffen, Kristine J and Sorgen, Alicia A and Fodor, Anthony A and Carroll, Ian M and Crosby, Ross D and Mitchell, James E and Bond, Dale S and Heinberg, Leslie J},
title = {Early changes in the gut microbiota are associated with weight outcomes over 2 years following metabolic and bariatric surgery},
journal = {Obesity},
year = {2024},
volume = {32},
number = {11},
pages = {1985--1997},
doi = {10.1002/oby.24168}
}
EUVIMED